Article

Outcomes of surgery for neurogenic thoracic outlet syndrome (NTOS) in workers'
compensation are poor in a majority of patients, partly due to nonspecificity of
diagnosis. Most cases have no objective evidence of the presence of brachial
plexus dysfunction. Up to 20% of patients experience a new adverse event.
Objective neurologic signs and electrodiagnostic evidence of brachial plexus
dysfunction must be present before proceeding with invasive procedures. This guideline includes objective criteria that must be met before thoracic outlet
syndrome surgery can be approved in Washington State. Evidence does not support
the use of scalene blocks, botulinum toxin therapy, or vascular studies to
diagnose NTOS.
CI - Copyright (c) 2015 Elsevier Inc. All rights reserved.

Langue : ANGLAIS